SI-BONE, Inc.
SIBN
NASDAQ·Healthcare·Medical - Devices·Mkt cap $852.0M
$19.21
▲ +0.05%
P/E
-43.66
Mkt Cap
$852.0M
52-Wk Range
$11.48–$21.89
52-Week Range
$11.48 - $21.89
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 16.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary 3D-printed porous surface technology with fenestrated design
- Established market leadership in sacroiliac joint fusion with extensive clinical evidence
- Comprehensive product portfolio addressing multiple sacropelvic pathologies
- Strong intellectual property protection and patent portfolio
Bear Case
1 risk
- Low volatility (beta 0.7).
Growth
Moderate growth ahead
Rising prevalence of sacroiliac joint dysfunction and chronic lower back pain
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+36.2% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying SIBN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 9, 2026
AUG 3, 2026
Reported EPS of -$0.09 vs -$0.15 consensus (+39.8% surprise). Revenue of $56.0M vs $55.3M expected (+1.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+39.8%
Revenue trend · last 8Q
—
—
+26%
+25%
+22%
+21%
+11%
+15%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q1 26
Q2 26
$40.0M
$40.3M
$49.0M
$47.3M
$48.6M
$48.7M
$52.6M
$56.0M
Margins · last 8Q
Gross
79.5%
Operating
-8.6%
Profit
-7.3%
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: UBS · Aug 4, 2026
vs Industry
How SIBN stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related